フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that G?nter Blobel, M.D., Ph.D., has joined the Scientific...
Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that Narendra Vaish, Ph.D., MBA, Senior Research Scientist and...
Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK), in compliance with Nasdaq Marketplace Rule 4350(b)(1)(B), which requires...
Wall Street Media is presenting an exclusive highlight video from the presentation of Dr. Gordon Brandt, president of Nastech...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to...
Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) today reported financial results for the fourth quarter and year ended...
Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that it will present at the Invest Northwest CEO & Investor...
Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today that it has completed filing 83 patent applications (79...
Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today the appointment of a Scientific Advisory Board (SAB) for...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to...
BOTHELL, Wash., Feb. 29 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. (NASDAQ:NSTK) announced today that it will host a...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す